These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39070823)

  • 1. Hepatoid adenocarcinoma of the lung: A case report.
    Mo YJ; Lin LN; Tao JL; Zhang T; Zhang JH
    World J Clin Cases; 2024 Jul; 12(21):4813-4819. PubMed ID: 39070823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoid Adenocarcinoma of the Lung.
    Li M; Fan Y; Lu H
    Technol Cancer Res Treat; 2021; 20():15330338211057983. PubMed ID: 34816785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable
    Chen L; Han X; Gao Y; Zhao Q; Wang Y; Jiang Y; Liu S; Wu X; Miao L
    Onco Targets Ther; 2020; 13():4359-4364. PubMed ID: 32547068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
    Xu SZ; Zhang XC; Jiang Q; Chen M; He MY; Shen P
    World J Clin Cases; 2022 Oct; 10(28):10236-10243. PubMed ID: 36246828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.
    Hou Z; Xie J; Zhang L; Dai G; Chen Y; He L
    Front Oncol; 2021; 11():702216. PubMed ID: 34422656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report.
    Lagos GG; Feldman JL; Saqi A; Shu CA
    JTO Clin Res Rep; 2021 Feb; 2(2):100130. PubMed ID: 34589989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report.
    Li Y; Liu L; Wang D; Tan X; Sui Y; Yang H
    Front Oncol; 2023; 13():1257931. PubMed ID: 38074660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis.
    Deng H; Wang L; Li Z; Zhan T; Huang L
    BMC Cancer; 2024 Aug; 24(1):948. PubMed ID: 39095810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatoid adenocarcinoma of the lung with extremely elevated serum AFP: a case report and literature review.
    Cai C; Zhang N; Wang M; Wang L; Zhao H; Zhang X; Li B; Wang J
    Front Oncol; 2024; 14():1448219. PubMed ID: 39421450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.
    Chen Z; Ding C; Zhang T; He Y; Jiang G
    Onco Targets Ther; 2022; 15():609-627. PubMed ID: 35676912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases.
    Sun H; Li X; Zhang J; Liu Y
    Pathol Res Pract; 2022 Jan; 229():153652. PubMed ID: 34826742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.
    Sun JN; Zhang BL; Li LK; Yu HY; Wang B
    Oncol Lett; 2016 Jul; 12(1):189-194. PubMed ID: 27347123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report.
    Shi YF; Lu JG; Yang QM; Duan J; Lei YM; Zhao W; Liu YQ
    World J Clin Cases; 2019 Jul; 7(13):1711-1716. PubMed ID: 31367631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report.
    Huang X; Zhu L; Pan W; Hu J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2342133. PubMed ID: 38659098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoid adenocarcinoma of the lung and the review of the literature.
    Tonyali O; Gonullu O; Ozturk MA; Kosif A; Civi OG
    J Oncol Pharm Pract; 2020 Sep; 26(6):1505-1510. PubMed ID: 32041468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma.
    Yao Y; Guan X; Bao G; Liang J; Li T; Zhong X
    Front Pharmacol; 2022; 13():945038. PubMed ID: 36091765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review.
    Zhuansun Y; Bian L; Zhao Z; Du Y; Chen R; Lin L; Li J
    Cancer Treat Res Commun; 2021; 29():100474. PubMed ID: 34656923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
    Li J; Qi H; Xu B; Zhao J; Gao H; Ma X; Liu X
    Front Oncol; 2019; 9():1360. PubMed ID: 31921629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Lei L; Yang L; Xu YY; Chen HF; Zhan P; Wang WX; Xu CW
    Open Med (Wars); 2021; 16(1):169-174. PubMed ID: 33585692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases.
    Bonis A; Dell'Amore A; Verzeletti V; Melan L; Zambello G; Nardocci C; Comacchio GM; Pezzuto F; Calabrese F; Rea F
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.